S1P Therapeutics Inc wins VA Catalyst Grant Round 17
(March 4, 2025) S1P Therapeutics Inc is excited that our groundbreaking research in developing drugs for the treatment of kidney and autoimmune diseases has again been awarded a prestigious Virginia Catalyst grant. This recognition is a testament to the dedication of our exceptional team, who have tirelessly pursued innovations that have the potential to improve […]
S1P Therapeutics Inc presented at Sphingolipid Club Meeting, September 3-7, 2024 (Erlangen, Germany)
S1P Therapeutics Awarded a Virginia Catalyst Grant Round 15
Project: Blocking the S1P Pathway for Chronic Kidney Disease Therapeutics Company: S1P Therapeutics Inc (Blacksburg, VA) University collaborators: Virginia Tech and University of Virginia Funding amount: $500,000 S1P Therapeutics Inc is excited that our groundbreaking research in developing drugs for the treatment of kidney and autoimmune diseases has been awarded a prestigious Virginia Catalyst grant. This […]